Abstract Radiation‐induced brain necrosis (RIBN) is a serious late and irreversible complication after radiation therapy for primary or secondary brain tumors as well as head and neck tumors, and there is no effective treatment. In recent years, bevacizumab has been increasingly applied in the treatment of RIBN, which has been proven to yield certain efficacy and improve patient survival. However, the optimal treatment timing and regimen have been controversial and lack of basic consensus. In this article, research progress on these issues was briefly reviewed.
Han Shuai,Wang Wenyan,Zhou Huandi et al. Research progress on bevacizumab in the treatment of radiation‐induced brain necrosis[J]. Chinese Journal of Radiation Oncology, 2022, 31(8): 737-740.
Han Shuai,Wang Wenyan,Zhou Huandi et al. Research progress on bevacizumab in the treatment of radiation‐induced brain necrosis[J]. Chinese Journal of Radiation Oncology, 2022, 31(8): 737-740.
[1] Diagnoses and treatments of radiation‐induced brain injury: an expert consensus [J]. Chin J Neuromed, 2019, 18 (6): 541‐549.DOI: 10.3760/cma.j.issn.1671‐8925.2019.06.001 [2] Wu L, Chung YL.Tumor‐infiltrating t cell receptor‐beta repertoires are linked to the risk of late chemoradiation‐induced temporal lobe necrosis in locally advanced nasopharyngeal carcinoma[J]. Int J Radiat Oncol Biol Phys, 2019,104(1):165‐176.DOI: 10.1016/j.ijrobp.2019.01.002. [3] Lawrence BM, Yaacov RL, Thomas EM, et al.Radiation dose‐volume effects in the brain[J]. Int J Radiat Oncol Biol Phys, 2010, 76(3 Suppl): S20‐27.DOI: 10.1016/j.ijrobp.2009.02.091. [4] Mayo, C.Ellen Y.Thomas EM,et al.Radiation associated brainstem injury[J]. Int J Radiat Oncol Biol Phys, 2010,76(3 Suppl): S36‐41.DOI: 10.1016/j.ijrobp.2009.08.078. [5] Zhuang H, Shi S, Yuan Z, et al.Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues[J]. Mol Cancer, 2019,18(1):21.DOI: 10.1186/s12943‐019‐0950‐1. [6] Wang B, Wang D, Zhu Z, et al.The role of extracellular‐5'‐nucleotidase/CD73 in glioma peritumoural brain edema[J]. Neurol Sci, 2016,37(4):603‐611.DOI: 10.1007/s10072‐ 016‐2510‐4. [7] Zhuang H, Yuan X, Zheng Y, et al.A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis[J]. Sci Rep, 2016,6:24364.DOI: 10.1038/srep24364. [8] Delishaj D, Ursino S, Pasqualetti F, et al.Bevacizumab for the treatment of radiation‐induced cerebral necrosis: a systematic review of the literature[J]. J Clin Med Res, 2017,9(4):273‐280.DOI: 10.14740/jocmr2936e. [9] Durim D, Stefano U, Francesco P, et al.Bevacizumab for the treatment of radiation‐induced cerebral necrosis: a systematic review of the literature[J]. J Clin Med Res, 2017,9 (4):273‐280.DOI: 10.14740/jocmr2936e. [10] Gonzalez J, Kumar AJ, Conrad CA, et al.Effect of bevacizumab on radiation necrosis of the brain[J]. Int J Radiat Oncol Biol Phys, 2007,67(2):323‐326.DOI: 10.1016/j.ijrobp.2006.10.010. [11] Dashti SR, Spalding A, Kadner RJ, et al.Targeted intraarterial anti‐VEGF therapy for medically refractory radiation necrosis in the brain[J]. PED, 2015, 15 (1):20‐25.DOI: 10.3171/2014.9.PEDS14198. [12] Delishaj D, Ursino S, Pasqualetti F, et al.The Effectiveness of bevacizumab in radionecrosis after radiosurgery of a single brain metastasis[J]. Rare Tumors, 2015,7(4):6018.DOI: 10.4081/rt.2015.6018. [13] Zhuang H, Yuan X, Sun D, et al.Acquired‐resistance of bevacizumab treatment for radiation brain necrosis: a case report[J]. Oncotarget, 2016,7(11):13265‐13268.DOI: 10.18632/oncotarget.7724. [14] Furuuchi K, Nishiyama A, Yoshioka H, et al.Reenlargement of radiation necrosis after stereotactic radiotherapy for brain metastasis from lung cancer during bevacizumab treatment[J]. Respirat Invest, 2017, 55 (2):184‐187.DOI: 10.1016/j.resinv.2016.11.001. [15] Tan R, Michalski A, Saran F, et al.Initial response with paradoxical deterioration following bevacizumab for cerebral radiation necrosis[J]. Pediat Blood Cancer, 2017, 64(5):26313.DOI: 10.1002/pbc.26313. [16] Pillay SN, Alden T, Hartsell W, et al.Severe radiation necrosis successfully treated with bevacizumab in an infant with low‐grade glioma and tumor‐associated intractable trigeminal neuralgia[J]. Pediat Blood Cancer, 2016, 63 (9):1671‐1673.DOI: 10.1002/pbc.26055. [17] Hu QG, Zhao J, Xu J, et al.Long‐term relief of cerebral radiation necrosis treated with low‐dose bevacizumab ‐ a report of 2 cases[J]. Oncol Res Treat, 2017, 40 (3):133‐137.DOI: 10.1159/000455868. [18] Glitza IC, Guha TN, Amaria RN, et al.Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases[J]. Melanom Res, 2017, 27 (6):580‐584.DOI: 10.1097/CMR.0000000000000389. [19] Ma YF, Zheng CT, Feng YP, et al.Bevacizumab for the treatment of gammaknife radiosurgery‐induced brain radiation necrosis[J]. J Craniofac Surg, 2017, 28 (6), e569‐e571.DOI: 10.1097/SCS.0000000000003874. [20] Sadraei NH, Dahiya S, Chao ST, et al.Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience[J]. Am J Clin Oncol, 2015, 38 (3):304‐310.DOI: 10.1097/COC.0b013e31829c3139. [21] Furuse M, Nonoguchi N, Kuroiwa T, et al.A prospective, multicentre, single‐arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis(†)[J]. Neurooncol Pract, 2016,3(4):272‐280.DOI: 10.1093/nop/npv064. [22] Hongqing Zhuang HQ, Yuan XK, Chang JY, et al.Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation[J]. Oncotarget, 2016, 7(30), 48842‐48829.DOI: 10.18632/oncotarget.7768. [23] Xu YT, Rong XM, Hu WH, et al.Bevacizumab monotherapy reduces radiation‐induced brain necrosis in nasopharyngeal carcinoma patients: a randomized controlled trial[J]. Int J Radiat Oncol Biol Phys, 2018, 101 (5):1087‐1095.DOI: 10.1016/j.ijrobp.2018.04.068. [24] Dahl NA, Liu AK, Foreman NK, et al.Bevacizumab in the treatment of radiation injury for children with central nervous system tumors[J]. Childs Nerv Syst, 2019,35(11):2043‐2046.DOI: 10.1007/s00381‐019‐04304‐y. [25] Bodensohn R, Hadi I, Fleischmann DF, et al.Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis[J]. Strahlenther Onkol, 2020,196(1):70‐76.DOI: 10.1007/s00066‐019‐ 01521‐x. [26] Zhuang HQ, Shi SY, Yuan ZY, et al.Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues[J]. Mol Cancer, 2019, 18(1):323.DOI: 10.1186/s12943‐019‐0950‐1. [27] Miyatake SI, Nonoguchi N, Furuse M, et al.Pathophysiology, diagnosis,treatment of radiation necrosis in the brain[J]. Neurol Med Chir (Tokyo),2015, 55 (1):50‐59.DOI: 10.2176/nmc.ra.2014‐0188. [28] Aurelia K, Roman L, Josef NJ, et al.Gamma Knife surgery for benign meningioma[J]. J Neurosurg, 2007, 107(2): 325‐336.DOI: 10.3171/JNS‐07/08/0325. [29] Duan C, PerezTCJ, Yuan L, et al.Can anti‐vascular endothelial growth factor antibody reverse radiation necrosis? A preclinical investigation[J]. J Neurooncol, 2017, 133 (1):9‐16.DOI: 10.1007/s11060‐017‐2410‐3.
2022, Vol. 31 
